Biogen: Wedbush raises target price to $225 from $212
BIIB•Wedbush raised its target price for Biogen to $225 from $212.
Related News
Annovis Bio participates in U.S. Biotech Day and Pharma Partnering Summit
ANVS•
Archer Aviation partners with ITA Airways to develop air taxi services in Italy
ACHR•
Tessera subsidiary Zorronet wins additional antenna order from Israeli defense organization
HLSQ•
Raymond James raises Q2 Holdings target price to $80 from $75
QTWO•
L.B. Foster acquires Dulworth operating assets for about $52.2 million
FSTR•